Andere talen Bio Vitos Pharma AB

Aandelen

BIOVIT

SE0009320278

Beurs gesloten - Nasdaq Stockholm Andere beurzen 12:24:26 07-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,132 ^SEK	+10,00%		-0,75%	-44,54%

14/02	Bio Vitos Pharma AB (publ) rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
14/02	Bio Vitos Pharma AB (publ) rapporteert resultaten voor het vierde kwartaal eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	14/02
Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes	12/02
KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer	12/02
KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer	12/02
The European Patent Office EPO grants patent that is important to Bio Vitos Pharma	20/12
The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB	20/12
Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC	06/12
Hemcheck Sweden AB will Change its Name to Bio Vitos Pharma AB	06/12
Hemcheck Sweden AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11
Hemcheck completes the transaction with Bio Vitos	20-10-23
Hemcheck Sweden AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30-08-23
Hemcheck has received a first order from its distributor Astemed	15-05-23
Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed	15-05-23
Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023	09-05-23
Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement	04-05-23
Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)	26-04-23
Hemcheck Sweden Receives New Follow Up Order from the Foundation for Innovative New Diagnostics	26-04-23
Hemcheck has received a first order from the university hospital Charité in Berlin	05-04-23
Hemcheck Sweden AB Receives First Order from the University Hospital Charité in Berlin	05-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bio Vitos Pharma AB

Aandelen

BIOVIT

SE0009320278

Andere talen

Filters